AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Lorisita-M50 Tablet

Prescription Icon
Prescription Required

Marketer

Lorioxindia Pharmaceuticals Private Limited

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Lorisita-M50 Tablet

Diabetol-Duo 50mg tablets combine two medications to manage elevated blood glucose in type 2 diabetes patients. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, potentially lowering heart attack and stroke risks. Diabetol-Duo 50mg may be used alone or with other diabetes treatments. Optimal results require adherence to a healthy diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and current medications. Taking it with food minimizes stomach upset. Consistent daily dosing at the same time maximizes effectiveness; discontinue only under your doctor's guidance. Maintaining your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Low blood sugar (hypoglycemia) is possible, especially with insulin or sulfonylurea use; learn to identify and manage this. This medication isn't suitable for everyone. Inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or excessive alcohol consumption before starting. Pregnant or nursing women should seek medical advice. Interactions with other drugs are possible; disclose all medications to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of Lorisita-M50 Tablet

Managing type 2 diabetes

Major Benefits of Lorisita-M50 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Lorisita-M50 with a meal.

Common Side effects of Lorisita-M50 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Lorisita-M50 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Lorisita-M50 Tablets. Ingest each tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Lorisita-M50 Tablet works:

Lorisita-M50 tablets combine sitagliptin and metformin to manage blood sugar. Sitagliptin boosts insulin production by the pancreas, enhances the body's insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Lorisita-M50 Tablet and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Lorisita-M50 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Lorisita-M50 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Lorisita-M50 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Lorisita-M50 Tablet use. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverUNSAFE

Patients with liver conditions should not take Lorisita-M50 tablets; use is strongly discouraged. Medical advice is recommended.

What if you forget to take Lorisita-M50 Tablet :

Should you forget a Lorisita-M50 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Lorisita-M50 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Lorisita-M50 Tablet

Lorisita-M50 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. Lorisita-M50 is not suitable for individuals under 18.
Prolonged Lorisita-M50 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left untreated. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Lorisita-M50 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Lorisita-M50 Tablet is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lorisita-M50 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Lorisita-M50 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Lorisita-M50 Tablet combines sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not for use in individuals under 18 years old.
Lorisita-M50 Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Lorisita-M50 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lorisita-M50 Tablet and alcohol is unsafe due to the increased risk of lactic acidosis.
Lorisita-M50 (containing metformin) can cause lactic acidosis, a serious medical emergency resulting from excess lactic acid in the blood (also known as MALA – Metformin-associated lactic acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow heart rate. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Lorisita-M50 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency may cause anemia and neurological issues, including numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Lorisita-M50 Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Lorisita-M50 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Lorisita-M50 Tablet is contraindicated in patients with known hypersensitivity to any component or excipient. It should also be avoided in those with severe renal or hepatic impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Lorisita-M50 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Lorisita-M50 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea/vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged Lorisita-M50 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Lorisita-M50 Tablet
86
MRP 100
14% off